Logo image of ZBIO

ZENAS BIOPHARMA INC (ZBIO) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:ZBIO - US98937L1052 - Common Stock

20.09 USD
-0.31 (-1.52%)
Last: 1/23/2026, 8:00:02 PM
20.11 USD
+0.02 (+0.1%)
After Hours: 1/23/2026, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ZBIO revenue by date.ZBIO revenue by date.
50M5M
-90.00%
29.75M
495.00%

-100.00%
52.712M140.89M
167.28%
274.71M
94.98%
461.98M
68.17%
717.82M
55.38%
970.08M
35.14%
1.2B
23.70%
EBITDA
YoY % growth
ZBIO ebitda by date.ZBIO ebitda by date.
-75.121M-27.034M
64.01%
-163.751M
-505.72%
-207.551M
-26.75%
-253.34M
-22.06%
-276.486M
-9.14%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ZBIO ebit by date.ZBIO ebit by date.
-75.199M-27.147M
63.90%
-163.888M
-503.71%
-178.827M
-9.12%
-258.6M
-44.61%
-263.814M
-2.02%
-267.556M
-1.42%
-179.449M
32.93%
-53.433M
70.22%
99.651M
286.50%
349.87M
251.10%
524.14M
49.81%
Operating Margin
ZBIO operating margin by date.ZBIO operating margin by date.
N/A-54.29%-3,277.76%-601.10%N/A-500.48%-189.90%-65.32%-11.57%13.88%36.07%43.68%
EPS
YoY % growth
ZBIO eps by date.ZBIO eps by date.
N/AN/AN/A-4.15
44.46%
-4.65
-12.10%
-4.44
4.46%
-3.14
29.28%
-2.39
24.03%
-1.02
57.26%
0.58
157.00%
2.36
305.26%
4.03
71.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-1.05
73.72%
-1.20
-49.43%
-1.10
12.32%
-1.10
9.87%
-0.79
25.10%
-1.27
-6.06%
2.33
312.56%
-1.23
-12.06%
-1.23
-55.97%
Revenue
Q2Q % growth
39.1M
682.00%

-100.00%
36.142M
-7.57%
1.624M76.5M1.679M5.454M
-84.91%
EBITDA
Q2Q % growth
-55.102M
0.69%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-38.84M
30.17%
-60.377M
-61.74%
-61.585M
-11.64%
-62.816M
-32.02%
-19.192M
50.59%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.22
75.70%
-1.07-0.15-14.17%
Q2 2025
Q2Q % growth
-1.25 -1.07-0.18-16.71%
Q1 2025
Q2Q % growth
-0.80 -1.130.3329.34%
Q4 2024
Q2Q % growth
-3.99 -1.02-2.97-290.79%
Q3 2024
Q2Q % growth
-5.02 -9.514.4947.24%
ZBIO Yearly EPS VS EstimatesZBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
10.2M-10.2M-100.00%
Q2 2025
Q2Q % growth
1.275M-1.275M-100.00%
Q1 2025
Q2Q % growth
10M 1.7M8.3M488.24%
Q3 2024
Q2Q % growth

-100.00%
%
ZBIO Yearly Revenue VS EstimatesZBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 7.04% -10.15% 3.47%
Revenue0% 283.33% -30% 25%